RWE has the power to change lives. It can allow for new treatments to come to market faster, but most importantly it provides valuable insight on how they perform where it really counts: real life.

To harness the full potential of RWE for treatment optimisation and research, we need to unlock the most critical data scource: hospital data.

In the past, the siloed nature of hospital systems and privacy concerns served as a major bottleneck for it’s inclusion in RWE generation strategies.

As a result, traditional RWE generation efforts relied on accessible but sub-par data sources, leading to data relevance issues and incomplete datasets. The only resort used to be chart review and Observational studies, which are in many cases prohibitively expensive.

Currently, only around 20% of hospital data is used for outcomes improvement and research. The remaining 80% is scattered and unstructured. As a result, this data is not available for research collaborations with other stakeholders.

LynxCare helps hospitals harmonize and aggregate their structured & unstructured data into a clinical grade OMOP data warehouse, unlocking a previously untapped source of RWD.

As the hospital remains in control of the data, it can be made available for research collaborations with the Life Sciences industry - without transfer of data ownership. This is the concept of a federated approach, as shared by the European Health Data and Evidence Network.

Additionally, data stored in OMOP format adheres to the FAIR data principle. This allows Hospitals to participate in federated data networks, enabling multi-center, multi-stakeholder RWE collaborations.